The Journal of Antibiotics

The Journal of Antibiotics
DisciplineMicrobiology
LanguageEnglish
Edited byKuniaki Tatsuta
Publication details
History1948–present
Publisher
FrequencyMonthly
3.3 (2022)
Standard abbreviations
ISO 4J. Antibiot.
NLMJ Antibiot (Tokyo)
Indexing
CODENJANTAJ
ISSN0021-8820 (print)
1881-1469 (web)
OCLC no.01642415
Links

The Journal of Antibiotics is a peer-reviewed medical journal published by the Nature Publishing Group for the Japan Antibiotics Research Association.

The journal seeks to endorse studies on antibiotics and associated types of biologically-active substances.

In June 2020, the journal published a pioneer systematic review on ivermectin and COVID-19 by Fatemeh Heiday and Reza Gharebaghi which has become highly cited.[1]

Abstracting and indexing

The journal is abstracted and indexed for example in:

According to the Journal Citation Reports, the journal has a 2022 impact factor of 3.3.[6]

References

  1. ^ Heidary, Fatemeh; Gharebaghi, Reza (2020). "Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen". The Journal of Antibiotics. 73 (9): 593–602. doi:10.1038/s41429-020-0336-z. ISSN 0021-8820. PMC 7290143. PMID 32533071.
  2. ^ "Serials cited". CAB Abstracts. CABI. Retrieved 2014-12-27.
  3. ^ a b "Master Journal List". Intellectual Property & Science. Thomson Reuters. Retrieved 2024-02-12.
  4. ^ "The Journal of Antibiotics". NLM Catalog. National Center for Biotechnology Information. Retrieved 2014-12-27.
  5. ^ "Source details: The Journal of Antibiotics". Scopus Preview. Nature Publishing Group. Retrieved 2024-02-12.
  6. ^ "Journals Ranked by Impact: The Journal of Antibiotics". 2022 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2023.


Stub icon 1 Stub icon 2

This article about a microbiology journal is a stub. You can help Wikipedia by expanding it.

See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page.